Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29669697

COc1cccc2cc(-c3nn(CCCCN)c4ncnc(N)c34)[nH]c12.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 4/20 0.54
▸ PIK3CD O00329 4/20 0.54
▸ PIK3CA P42336 3/20 0.54
▸ FGFR2 P21802 9/20 0.44
▸ FGFR1 P11362 8/20 0.44
▸ FGFR3 P22607 8/20 0.44
▸ RET P07949 4/20 0.44
▸ KDR P35968 3/20 0.44
▸ FGFR4 P22455 5/20 0.43
▸ MTOR P42345 3/20 0.43
▸ PRKDC P78527 2/20 0.43
▸ RIPK2 O43353 1/20 0.43
▸ NQO2 P16083 1/20 0.43
▸ CSNK2A2 P19784 1/20 0.43
▸ FECH P22830 1/20 0.43
▸ ACVR1B P36896 1/20 0.43
▸ TGFBR1 P36897 1/20 0.43
▸ MAPK10 P53779 1/20 0.43
▸ MAP2K5 Q13163 1/20 0.43
▸ BMPR2 Q13873 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL21528272 1.00 PIK3CG (0.54) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
SCHEMBL30405620 0.92 PIK3CD (0.60) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
SCHEMBL21528027 0.92 PIK3CD (0.60) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
SCHEMBL20553552 0.89 PIK3CD (0.45) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
Trifluoroacetic Acid SCHEMBL20553551 0.89 PIK3CD (0.56) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
Trifluoroacetic Acid SCHEMBL29669807 0.89 PIK3CD (0.56) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
SCHEMBL23157408 0.83 PIK3CD (0.51) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
SCHEMBL30405222 0.81 PIK3CD (0.64) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
SCHEMBL20552797 0.81 PIK3CD (0.64) PIK3CGPIK3CDPIK3CAFGFR2FGFR1
Trifluoroacetic Acid SCHEMBL21528139 0.80 RET (0.54) PIK3CGPIK3CDPIK3CAFGFR2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11364300-B2 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors Revolution Medicines, Inc. (US) 2022-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11364300-B2 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors MTOR, RICTOR, RPTOR PIK3CG 120/4885PIK3CD 94/4885PIK3CA 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback